University of Missouri School of Medicine MU Health School of Medicine
News Divider
Join us on Facebook!   Follow us on Twitter!   Subscribe to us!      


Sun
Hongmin Sun, PhD, assistant professor of internal medicine at the University of Missouri, has collaborated with researchers at the University of Michigan to develop an alternative to fighting the bacteria that cause strep throat (pictured in background). Strep and similar infections affect an estimated 700 million people around the world each year.


Researchers Find New Compound to Fight Strep Throat Infection


Antibiotic alternative revealed in Proceedings of the National Academy of Sciences

Researchers have discovered a promising alternative to common antibiotics used to fight the bacteria that cause strep throat. In an article published in the Proceedings of the National Academy of Sciences, the scientists discussed how their discovery could fight the infection with a reduced risk of antibiotic resistance.

By screening tens of thousands of small molecules, the team from the University of Missouri and University of Michigan identified a class of chemical compounds that significantly reduced the severity of group A Streptococcus (GAS) bacteria infection in mice. Their work suggests that the compounds might have therapeutic value in the treatment of strep and similar infections that affect an estimated 700 million people around the world each year. The newly identified compounds could work with conventional antibiotics, such as commonly prescribed penicillin, and result in more effective treatment.

"We know that 70 percent of bacteria causing infections in the hospital are resistant to at least one of the drugs commonly used for treatment," said Hongmin Sun, PhD, the article's first author and an assistant professor of internal medicine at the University of Missouri. "Rather than killing off the bacteria, this new compound changes the behavior of the bacteria and makes it less harmful."

Current antibiotics interfere with critical biological processes in the pathogen to kill it or stop its growth. But at the same time, stronger strains of harmful bacteria can sometimes resist the treatment and flourish.

"The widespread occurrence of antibiotic resistance among human pathogens is a major public health problem," said David Ginsburg, MD, a professor of internal medicine, human genetics, and pediatrics at the University of Michigan and a Howard Hughes Medical Institute investigator.

Ginsburg and Sun collaborated on a research team that included Scott Larsen, PhD, research professor of medicinal chemistry and co-director of the Vahlteich Medicinal Chemistry Core at the University of Michigan's College of Pharmacy. Work on this project is continuing in Sun's lab at the University of Missouri and at the University of Michigan, including the preparation of new compounds with improved potency and the filing of patents, Larsen said.





News and Events

Hwang Key Component in Protein that Causes Cystic Fibrosis Identified
Findings may lay foundation for the development of medications

SOM Graduation 2015 MU School of Medicine to Award 101 Medical Degrees at Commencement
Forty-five will remain in Missouri for specialty training in residency

George Kracke Potential New Painkiller Provides Longer Lasting Effects
Early studies show promise for alternative type of anesthetic

Durante Enzyme Responsible for Obesity-Related Hypertension Identified
Discovery may lead to new treatment options for arterial disease caused by obesity

Family Medicine AAFP Award MU Family Medicine Ranked Among Nation’s Best by AAFP
Medical school in top 10 for helping build family physician workforce

Legacy Teachers Medical Students Thank Legacy Teachers
MU’s unique program celebrates patients’ role in teaching future physicians

58th Alumni awards Eight Graduates and Supporters Receive 58th Annual Alumni Awards
Syed Arshad Husain presented with top honor

St. Baldricks Participants Go Bald for Childhood Cancer Research
Community donates more than $33,000 to the cause

Teresa Lever, MD New Model Could Help Identify Root Cause of Swallowing Disorder
Findings may ‘change the landscape’ of dysphagia intervention


Medzou Golf Tournament Spend a Day on the Greens to Fund a Free Community Health Clinic
Money raised helps MedZou clinic care for uninsured mid-Missourians

Laine Young-Walker, MD Bridging the Gap in Psychiatric Care for Children
MU School of Medicine program expands access in Boone County




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.